GlassScriptPhysician profile
Jason Barnes
NPI 1154851079
$3,430.24
in general payments reported to CMS, 2019-2025
21 companies · $641 in 2025
The $641 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.84 · 2021: $73.87 · 2022: $1,466 · 2023: $339 · 2024: $860 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,838.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,486.17 | 2022-2025 | Inspire |
| Genzyme Corporation | $593.26 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $244.17 | 2024-2025 | Dupixent |
| Optinose US, INC. | $158.91 | 2022-2025 | |
| Aerin Medical INC. | $148.46 | 2024 | |
| Glaxosmithkline, LLC. | $113.98 | 2024-2025 | Nucala |
| Alk-Abello, INC | $99.72 | 2022-2025 | Odactra, Ragwitek, Grastek |
| Acclarent, INC | $97.19 | 2022 | |
| Allergan, INC. | $73.87 | 2021 | |
| Stryker Corporation | $67.88 | 2019-2025 | Audion Et Dilation System |
| Hikma Pharmaceuticals USA | $63.89 | 2023-2024 | Ryaltris |
| Kaleo, INC. | $52.13 | 2023-2024 | Auvi-Q |
| Medtronic, INC. | $40.83 | 2022-2025 | Propel |
| Paratek Pharmaceuticals, INC. | $33.61 | 2025 | Xhance |
| Integra Lifesciences Corporation | $28.71 | 2023-2024 | Integra, Instruments-Orthopedic, Codman Isocool Aht |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $27.99 | 2025 | Vevye |
| Ars Pharmaceuticals Operations, INC. | $26.18 | 2025 | Neffy |
| Abbvie INC. | $23.97 | 2025 | |
| Boston Scientific Corporation | $18.35 | 2022 | |
| Smith+Nephew, INC. | $15.78 | 2023 | Coblation |
| Merck Sharp & Dohme LLC | $15.19 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.